Home | Drugs Approvals and Trials

Drugs Approvals and Trials

VCU-developed compound continues phase 1 clinical trials

The novel therapeutic candidate has broad applications in organ injuries and metabolic diseases ...

Australian researcher helps with Ebola vaccine trials

An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines. ... Full story

New hope for patients as large-scale stem cell trials for osteoarthritis expected

Professor Frank Barry, Scientific Director of the Regenerative Medicine Institute (REMEDI), NUI Galway ... Full story

“Made in Michigan” times three: First clinical trials begin for drug developed at U-M and licensed to a U-M spinoff based on campus

Lycera drug will be tested in Crohn’s and ulcerative colitis patients even as cooperative research continues with U-M Medical School teams ... Full story

Clinical trial for guanabenz as treatment for Multiple Sclerosis begins enrollment

Patients are now being enrolled in a clinical trial conducted to study guanabenz, an FDA-approved drug to treat high blood pressure, as a potential therapeutic to reduce loss of myelin in multiple sclerosis (MS) patients. ... Full story

Yale researchers test drug for Wilson Disease in clinical trial

A copper ring, known as Kayser Fleischer ring, appears in the Descemet's membrane of the cornea of a Wilson disease patient. (Image by Dr. Joel Geffen) ... Full story

FDA approves first generic Copaxone to treat multiple sclerosis

The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS). ... Full story

NIH launches largest clinical trial focused on HIV-related cardiovascular disease

Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Allergy and Infectious Diseases (NIAID). ... Full story

On the way to a new tuberculosis vaccine

VPM1002 is being tested in clinical trials as a tuberculosis vaccine in newborns and as a drug against cancer of the bladder ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 522 | displaying: 1 - 10